Insider Transactions in Q2 2024 at Option Care Health, Inc. (OPCH)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 19
2024
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-0.57%
|
$6,902
$29.78 P/Share
|
May 19
2024
|
Collin Smyser GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
812
+1.89%
|
-
|
May 19
2024
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,522
-5.48%
|
$44,138
$29.78 P/Share
|
May 15
2024
|
Eric Brandt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+50.0%
|
-
|
May 15
2024
|
Natasha Deckmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,985
+26.62%
|
-
|
May 15
2024
|
Elizabeth D Bierbower Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+22.04%
|
-
|
May 15
2024
|
Elizabeth Quadros Betten Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+7.18%
|
-
|
May 15
2024
|
John Arlotta Director |
BUY
Grant, award, or other acquisition
|
Indirect |
9,150
+11.41%
|
-
|
May 15
2024
|
R Carter Pate Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+4.83%
|
-
|
May 15
2024
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,806
+4.65%
|
-
|
May 15
2024
|
David W Golding Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,219
+5.49%
|
-
|
May 15
2024
|
Barbara W. Bodem Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+43.01%
|
-
|
May 15
2024
|
Norman L. Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+43.01%
|
-
|
May 15
2024
|
Timothy P Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,325
+7.26%
|
-
|
May 09
2024
|
R Carter Pate Director |
SELL
Bona fide gift
|
Direct |
6,504
-6.13%
|
-
|
Apr 22
2024
|
Femi Adewunmi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,867
+50.0%
|
-
|
Apr 01
2024
|
Norman L. Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,731
+50.0%
|
-
|
Apr 01
2024
|
Barbara W. Bodem Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,731
+50.0%
|
-
|